Hetero Biopharma Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24290TG2016PLC111946 Incorporated 14 September 2016 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Public Limited Company pharma
Revenue · FY 2026
₹525.07 Cr
▲ 31% YoY
Net profit · FY 2026
₹33.5 Cr
Net margin 6.4%
EBITDA · FY 2026
₹119.5 Cr
EBITDA margin 22.8%
Authorised capital
₹207 Cr
Registered with MCA
Paid-up capital
₹150.05 Cr
Issued & subscribed
Open charges
₹252.15 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Employees · EPFO
444
Provident fund records

About Hetero Biopharma Limited

Data last updated:

Hetero Biopharma Limited is a public limited company based in Hyderabad, Telangana, India, a subsidiary of Hetero Labs Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 September 2016 and has been in existence for over 10 years.

Its director B Parthasaradhi Reddy and family are #70 among India's richest people (2026).

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2016PLC111946. Its GSTIN is 36AADCH9806P1ZY (Telangana). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹207 Cr and a paid-up capital of ₹150.05 Cr. It was formerly known as Hetero Biopharma Ltd. It is led by directors including Bandi Vamsikrishna and Govindaraju Bhavani.

Its last annual general meeting (AGM) was held on 28 August 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Hyderabad, Telangana.

As per the financials filed for FY 2026, the company reported a revenue of ₹525.07 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹33.5 Cr (net margin 6.4%) and EBITDA of ₹119.5 Cr (EBITDA margin 22.8%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 32% over five years.

The company has about 444 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 2 brands: Hetero Biopharma and Hetero. As per MCA filings, the company has open charges of ₹252.15 Cr on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹150 Cr; the latest was in March 2019. The company has 14 MSME Form 1 returns on record between 2019 and 2024, listing 212 overdue payments to 31 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hetero.com.

Company details

CIN U24290TG2016PLC111946
Registration Number 111946
Incorporation Date 14 September 2016
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Parent Company Hetero Labs Limited
Compliance Status Active Compliant

Recognitions & Rankings of Hetero Biopharma

Contact details

Hetero Biopharma Limited's registered office is in Hyderabad, Telangana. Its website is hetero.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Social Media
  • Registered Address
    #7 – 2 – A2 Industrial Estate, Sanath Nagar, Hyderabad, Telangana, India – 500018
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Hetero Biopharma Limited, buy the company report.

Comprehensive company report
Hetero Biopharma Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Hetero Biopharma operates two associated brands: Hetero Biopharma and Hetero. Each brand links to its own profile.

BrandDescriptionWebsite
Development and manufacturing of biosimilars and biopharmaceuticals are conducted by Hetero Biopharma in the healthcare sector.heterobiopharma.com
Hetero is recognized as a leading global pharmaceutical company based in India.hetero.com

Business activity

The main business activity of Hetero Biopharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of Hetero Biopharma Limited, buy the company report.

Financials of Hetero Biopharma Limited

FY 2026 filings available

Hetero Biopharma Limited reported revenue of ₹525.07 Cr (up 31% YoY) for FY 2026.

Revenue · FY 2026
₹525.07 Cr ▲ 31%
Net profit · FY 2026
₹33.5 Cr margin 6.4%
EBITDA · FY 2026
₹119.5 Cr margin 22.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 31%
3 years · compounded
▲ 15%
5 years · compounded
▲ 32%
EBITDA CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 3%
5 years · compounded
▲ 55%

Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 31% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹525.07 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹119.5 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹33.5 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin22.8%
Net Profit Margin6.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Hetero Biopharma Limited, buy the company report.

Board of directors of Hetero Biopharma Limited

Hetero Biopharma has 4 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Bandi VamsikrishnaDirector25 Mar 20215 Years 7 MonthsCurrent
Govindaraju BhavaniDirector26 Aug 20224 Years 2 MonthsCurrent
Parthasaradhi Reddy BandiDirector14 Sep 201610 Years 2 MonthsCurrent
Bhaskarreddy PabbatireddyAdditional Director26 Sep 20251 Years 1 MonthsCurrent

Auditor

Hetero Biopharma Limited is audited by M V Narayana Reddy & Co for the financial year 2026.

Auditor firmFinancial yearFirm registration number
M V Narayana Reddy & CoFY 2026002370S

Shareholding

The shareholding of Hetero Biopharma Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2026FY 2025FY 2024FY 2023FY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Hetero Biopharma Limited, buy the company report.

Charges & borrowings

Open charges
₹252.15 Cr
Satisfied charges
None
Breakdown by lending institutions
Sbicap Trustee Company Limited₹158.00 Cr
Others₹94.15 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Mar 2025101078891Sbicap Trustee Company Limited₹75 CrOpen
27 Mar 2025101077053Sbicap Trustee Company Limited₹83 CrOpen
14 Feb 2024100890394Others₹25 LakhOpen
20 Feb 2023100687093Others₹20 LakhOpen
07 Jun 2022100607618Others₹97.93 LakhOpen

To see the full charge records of Hetero Biopharma Limited, buy the company report.

Total charge records: 6 View all charges

Deals & funding

Hetero Biopharma Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹150 Cr; the latest was in March 2019.

Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹150 Cr

Deals on record (1 of 2)

WhenDealAmountParties
Mar 2017Secondary share transferUndisclosedBuyer: Hetero Labs Limited & Mohan Reddy Chilukuri
Seller: Hetero Labs Limited & Chandra Sekhar Tummuluru

To see the full deal history of Hetero Biopharma Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Hetero Biopharma Limited has 14 MSME Form 1 returns on record between 2019 and 2024, listing 212 overdue payments to 31 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 31)

SupplierAmount dueDue sinceReported on
Nicomac Taikisha Clean Rooms Private Limited
an individual supplier
Devson Impex Private Limited
LCGC Chrom Consumables LLP
PJB Projects Private Limited

To see the full MSME payment records of Hetero Biopharma Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Hetero Biopharma has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Hetero Plasma Sciences Private LimitedU46497TS2023PTC175917

To see the full group structure of Hetero Biopharma Limited, buy the company report.

Employees & EPFO

Hetero Biopharma Limited has a workforce of 444 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
444
Active EPFO establishments
1
Employee growth
-4.9%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27444
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18

To see the full employee and EPFO history of Hetero Biopharma Limited, buy the company report.

GST

Hetero Biopharma has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
36AADCH9806P1ZYTelanganaActive01 Jul 2017
36AADCH9806P2ZXTelanganaActive06 Jul 2017

To see the full GST registrations and return filing status of Hetero Biopharma Limited, buy the company report.

Recent activity

Hetero Biopharma Limited has 13 board changes on record since 2016: 6 appointments and 7 cessations. The latest: Bhaskarreddy Pabbatireddy was appointed as Additional Director on 26 Sep 2025.

Filing
Hetero Biopharma Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Hyderabad.
Appointed
Bhaskarreddy Pabbatireddy was appointed as Additional Director.
AGM
Hetero Biopharma Limited last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records.
Charges
A charge with Sbicap Trustee Company Limited amounted to Rs. 75.00 Cr with Charge ID 101078891 was registered on 27 Mar 2025.
Charges
A charge with Sbicap Trustee Company Limited amounted to Rs. 83.00 Cr with Charge ID 101077053 was registered on 27 Mar 2025.
Charges
A charge with Others of Rs. 92.72 Cr registered on 14 Sep 2021 with Charge ID 100482619 was modified on 17 Dec 2024.
Ceased
Bhavesh Bansidhar Pujara ceased to be Additional Director.
Appointed
Bhavesh Bansidhar Pujara was appointed as Director.
Charges
A charge with Others amounted to Rs. 0.25 Cr with Charge ID 100890394 was registered on 14 Feb 2024.
Charges
A charge with Others amounted to Rs. 0.20 Cr with Charge ID 100687093 was registered on 20 Feb 2023.
Ceased
Govindaraju Bhavani ceased to be Additional Director.
Appointed
Govindaraju Bhavani was appointed as Director.

11 earlier events are in the company report.

Frequently asked questions

Hetero Biopharma is an active public limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 September 2016 (10+ years old) and is registered under CIN U24290TG2016PLC111946.

Hetero Biopharma has 4 current directors:

The latest financial statements of Hetero Biopharma on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 28 August 2025. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Hetero Biopharma is 36AADCH9806P1ZY, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AADCH9806P2ZX (Telangana).

The CIN (Corporate Identification Number) of Hetero Biopharma is U24290TG2016PLC111946. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Hetero Biopharma has 2 court cases on record: 2 filed against it. 1 is pending.

Hetero Biopharma was incorporated on 14 September 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.

Hetero Biopharma has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹150 Cr; the latest was in March 2019.

Bhaskarreddy Pabbatireddy was appointed as Additional Director on 26 Sep 2025. Bhavesh Bansidhar Pujara ceased to be Additional Director on 18 Sep 2024. Bhavesh Bansidhar Pujara was appointed as Director on 14 Jun 2024. Hetero Biopharma has 13 board changes on record in total.

Hetero Biopharma has 14 MSME Form 1 returns on record between 2019 and 2024, listing 212 overdue payments to 31 micro and small suppliers. The latest return was filed on 30 Apr 2024.

Hetero Biopharma can be reached through the website hetero.com. Its registered office is in Hyderabad, Telangana, India.